Wikidata

(Q61070970)

English

A Study of Selicrelumab (RO7009789) in Combination With Atezolizumab in Participants With Locally Advanced and/or Metastatic Solid Tumors

clinical trial

In more languages

Statements

title
An Open-Label, Multicenter, Dose-Escalation Phase IB Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Therapeutic Activity of RO7009789 (CD40 Agonist) in Combination With Atezolizumab (Anti PD-L1) in Patients With Locally Advanced and/or Metastatic Solid Tumors (English)
0 references
sponsor
Hoffmann-La Roche
0 references
country
Canada
0 references
Denmark
0 references
France
0 references
Netherlands
0 references
Spain
0 references
start time
12 December 2014
0 references
end time
3 October 2019
0 references
number of participants
230
0 references
research intervention
atezolizumab
0 references
selicrelumab
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61070970&oldid=2063560705"